Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1042 of 6351
-
New blood test could spot cancer early – 6,000+ join study
Diagnosis Recruiting nowThis study explores the potential value of a new blood test approach for early detection of cancer.
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
New combo therapy shows promise for tough lung cancer
Disease control CompletedDurvalumab is a drug that stimulates the immune system to fight lung cancer. Durvalumab is FDA approved to treat lung cancer. Stereotactic body radiation therapy (SBRT) is a newer radiation treatment that gives fewer, but higher doses of radiation than standard radiation. With S…
Phase 2 • Sponsor: Brown University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug combo aims to shrink tough colorectal tumors before surgery
Disease control Recruiting nowColorectal cancer of Mismatch Repair-deficient (dMMR)/ Microsatellite Instability-high (MSI-H) accounts for approximately 15% of all colorectal cancer patients, with a higher proportion in right colon cancer. Previous studies have found that colon cancer patients with dMMR/MSI-H …
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Sleep apnea treatment after stroke may save lives
Disease control OngoingThe purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ischemic stroke (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2)…
Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a High-Fat diet help nerves heal after spinal injury?
Disease control CompletedThe purpose of this project is to determine if 5 weeks of ketogenic (KD, high-fat) diet vs. standard diet (SD) significantly improves motor and sensory function, glycemic function, and functional independence in patients with spinal cord injury.
Sponsor: Ohio State University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a diabetes drug protect your eyes? 5-Year trial seeks answers
Disease control OngoingThis study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medicine). The study will be performed in people with type 2 diabetes. Participants will either get semaglutide or placebo in addition to their d…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
New combo therapy shows promise for Hard-to-Treat leukemia
Disease control Recruiting nowThis phase II trial studies how well inotuzumab ozogamicin and blinatumomab with or without ponatinib work in treating patients with CD22-positive B-lineage acute lymphoblastic leukemia that is newly diagnosed, has come back after a period of improvement (recurrent), or does not …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
New drug could help people with short bowel syndrome ditch IV nutrition
Disease control CompletedThe primary objective of the trial is to evaluate the long-term safety of glepaglutide treatment in patients with short bowel syndrome (SBS). Glepaglutide is the International Nonproprietary Name and USAN for ZP1848.
Phase 3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Personalized cell therapy shows promise but trial ends early
Disease control Stopped earlyA prospective, open-label, multi-cohort, non-randomized, multicenter Phase 2 study evaluating adoptive cell therapy (ACT) with TIL \[LN-144/LN-145 (lifileucel)\] in combination with immune checkpoint inhibitors or TIL \[LN-144/LN-145 (lifileucel) and LN-145-S1\] as a single agent…
Phase 2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug combo shows promise for Tough-to-Treat bladder cancer
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of lenvatinib (MK-7902/E7080) in combination with pembrolizumab (MK-3475) in the treatment of cisplatin-ineligible participants with a Programmed Cell Death-Ligand 1 (PD-L1) Combined Positive Score (CPS) ≥10, or in …
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Simpler HIV pill shows promise for teens in small trial
Disease control CompletedFirst-line antiretroviral regimens are highly efficacious and generally well tolerated. However, as these regimens need to be taken life-long, there is growing concern about long-term toxicities associated with these regimens. Thus, there is great interest from participants and c…
Phase 3 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a shot of your own blood boost fertility?
Disease control Recruiting nowAutologous PRP intra ovarian infusion may improve ovarian response, patients' hormonal profile as well as fresh embryo transfer (ET)-ICSI cycles' outcome in patients presenting with Poor Ovarian Response (POR).
Phase 2/3 • Sponsor: Genesis Athens Clinic • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Cortisone may be key to children's facial palsy recovery
Disease control CompletedAcute facial nerve palsy occur in 10-20/100 000 children/year in Sweden. About 20 % of these children will have persistent symptoms with excessive tear secretion, drooling and social problems due to asymmetry in the face. Studies on cortisone treatment to adult patients with acut…
Phase 4 • Sponsor: Dalarna County Council, Sweden • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Immunotherapy combo shows promise in esophageal cancer trial
Disease control PausedThis phase II/III trial studies the usefulness of treatment with nivolumab and ipilimumab in addition to standard of care chemotherapy and radiation therapy in patients with esophageal and gastroesophageal junction adenocarcinoma who are undergoing surgery. Immunotherapy with ant…
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New combo therapy shows promise for advanced nose cancer
Disease control OngoingThis is an open label, single arm, non-randomized, multi-site, phase 2 clinical trial of neoadjuvant pembrolizumab in combination with gemcitabine-cisplatin for 2 cycles,followed by concurrent pembrolizumab-cisplain-radiation, and then maintainence pembrolizumab monotherpy given …
Phase 2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Could chemo replace surgery for rectal cancer? new study explores
Disease control OngoingThe purpose of this study is to evaluate the treatment of patients with locally advanced rectal cancer for complete response to neoadjuvant chemotherapy without the use of radiation and surgery.
Phase 2 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could oxygen or a common drug fix Opioid-Linked sleep apnea?
Disease control Recruiting nowThere is an increased risk for sleep disordered breathing (SDB), sleep-related hypoventilation and irregular breathing in individuals on chronic prescription opioid medications. Almost 30% of a veteran sleep clinic population had opioid-associated central sleep apnea (CSA). The p…
Phase 1/2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Major trial seeks to end debate on ventilator strategies for kids
Disease control OngoingSevere pediatric acute respiratory distress syndrome (PARDS) is a life-threatening and frequent problem experienced by thousands of children each year. Little evidence supports current supportive practices during their critical illness. The overall objective of this study is to i…
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New triple therapy could improve diabetes control
Disease control OngoingTo assess whether the addition of dapagliflozin to semaglutide and insulin (triple therapy) improves glycemic control in patients with type 1 diabetes compared with semaglutide and insulin (dual therapy) and insulin only (standard) treatment.
Phase 2/3 • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Babble boot camp: could early talk therapy stop speech delays in rare disease?
Prevention CompletedA critical knowledge gap is whether proactive intervention can improve speech and language outcomes in infants at known risk for communication disorders. Speech and language assessments and treatments are usually not initiated until deficits can be diagnosed, no earlier than age …
Early phase 1 • Sponsor: Arizona State University • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC